• 1. Action of an extract from the seeds of Fraxinus excelsior L. on metabolic disorders in hypertensive and obese animal models
  Fermí Montó,Cristina Arce,Maria Antonia Noguera,Maria Dolores Ivorra,John Flanagan,Marc Roller,Nicolas Issaly,Pilar D'Ocon Food Funct. 2014 5 786
• 2. Analysis of phenylephrine hydrochloride in pharmaceutical formulations and biological fluids using (2,2′-bipyridyl)ruthenium(ii)-peroxydisulphate chemiluminescence system in a two-chip microdevice
  Haider A. J. Al Lawati,Mahmood Al-Azwani,Gouri B Varma,Fakhr Eldin O. Suliman,Khaled A. Shalabi Anal. Methods 2011 3 2585
• 3. Colorimetric determination of phenylephrine hydrochloride in pharmaceutical preparations
  Yehia M. Dessouky,Laila N. Gad El Rub Analyst 1976 101 717
• 4. Stereochemistry of optically active nickel(ii) and cobalt(ii) coordination compounds derived from N-acetyl aminoalcohols
  Gabriela Vargas-Díaz,Horacio López-Sandoval,Adriana B. Vázquez-Palma,Marcos Flores-Alamo,Adrián Pe?a-Hueso,Sonia A. Sánchez-Ruíz,Angelina Flores-Parra,Rosalinda Contreras,Norah Barba-Behrens Dalton Trans. 2007 4185
• 5. Stereochemistry of optically active nickel(ii) and cobalt(ii) coordination compounds derived from N-acetyl aminoalcohols
  Gabriela Vargas-Díaz,Horacio López-Sandoval,Adriana B. Vázquez-Palma,Marcos Flores-Alamo,Adrián Pe?a-Hueso,Sonia A. Sánchez-Ruíz,Angelina Flores-Parra,Rosalinda Contreras,Norah Barba-Behrens Dalton Trans. 2007 4185

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenols 1-hydroxy-4-unsubstituted benzenoids

Phenylephrine Hydrochloride: Chemical Profile and Contemporary Research Applications

Phenylephrine hydrochloride, with the chemical compound identifier CAS no. 61-76-7, is a well-established synthetic compound that has garnered significant attention in the field of pharmacology and medicine. This compound, classified as an alpha-adrenergic receptor agonist, is primarily recognized for its vasoconstrictive properties, which have made it a staple in various medical formulations and therapeutic interventions. The chemical structure of Phenylephrine hydrochloride consists of a phenethylamine core, modified by the addition of a hydrochloride salt, which enhances its solubility and bioavailability in aqueous solutions.

The mechanism of action for Phenylephrine hydrochloride is centered around its interaction with alpha-1 adrenergic receptors, predominantly found in vascular smooth muscle tissues. Upon binding to these receptors, the compound induces vasoconstriction, leading to an increase in blood pressure and a reduction in blood flow to certain regions of the body. This property is particularly valuable in clinical settings where localized vasoconstriction is desired, such as in the treatment of nasal congestion or during surgical procedures to reduce bleeding.

Recent advancements in pharmaceutical research have expanded the applications of Phenylephrine hydrochloride beyond traditional uses. Studies have begun to explore its potential role in managing conditions related to circulatory dynamics. For instance, research has indicated that Phenylephrine hydrochloride may be beneficial in the treatment of certain types of shock syndromes by helping to stabilize blood pressure levels. Additionally, its use in conjunction with other vasopressors has been investigated for improving hemodynamic stability in critically ill patients.

The chemical synthesis of CAS no 61-76-7, known chemically as Phenylephrine hydrochloride, involves a series of well-documented organic reactions. The process typically begins with the nitration of benzyl chloride to form p-nitrobenzyl chloride, followed by reduction to p-nitrobenzylamine. Subsequent substitution reactions introduce the amine group into an ethyl side chain, yielding phenethylamine. The final step involves converting phenethylamine into its hydrochloride salt form, which is crucial for enhancing its pharmacological activity and stability.

In clinical pharmacology, Phenylephrine hydrochloride is often formulated as an injectable solution or administered orally in nasal sprays and decongestants. The injectable form is particularly useful in emergency medical settings where rapid vasoconstriction is necessary. However, it is important to note that prolonged use or misuse can lead to adverse effects such as increased heart rate, elevated blood pressure, and potential tissue ischemia due to excessive vasoconstriction.

Recent research has also delved into the pharmacokinetic properties of Phenylephrine hydrochloride, aiming to optimize its delivery and efficacy. Studies have shown that controlled-release formulations can provide sustained therapeutic effects while minimizing side effects. This has opened up new avenues for developing more refined medical products that leverage the benefits of CAS no 61-76-7 without compromising patient safety.

The safety profile of Phenylephrine hydrochloride has been extensively evaluated through numerous clinical trials and pharmacological studies. While generally considered safe when used as directed, it is essential for healthcare professionals to be aware of contraindications and potential interactions with other medications. Patients with pre-existing cardiovascular conditions should use this compound under close medical supervision due to the risk of exacerbating their condition.

Future directions in the research of Phenylephrine hydrochloride are likely to focus on exploring novel therapeutic applications and improving existing formulations. Innovations such as targeted drug delivery systems and combination therapies could enhance its utility in treating a broader range of medical conditions. Additionally, ongoing studies may provide further insights into its mechanism of action and potential synergies with other pharmacological agents.

The role of Phenylephrine hydrochloride in emergency medicine continues to be a critical area of interest. Its ability to rapidly increase blood pressure makes it invaluable in situations where immediate circulatory support is needed. As emergency medical protocols evolve, so too will the applications and dosing regimens for this essential compound.

In conclusion, Phenylephrine hydrochloride (CAS no 61-76-7) remains a cornerstone in modern medicine due to its well-documented pharmacological properties and broad range of applications. Ongoing research continues to uncover new uses and refine existing treatments, ensuring that this compound will remain relevant for years to come.

• 582-84-3(synephrine)
• 150-05-0(D-(+)-Epinephrine)
• 329-65-7(DL-Epinephrine)
• 709-55-7(3-2-(ethylamino)-1-hydroxyethylphenol)
• 94-07-5(Synephrine)
• 554-99-4(1,2-Benzenediol,4-[2-(dimethylamino)-1-hydroxyethyl]-)
• 1219803-77-6((±)-Epinephrine-2,5,6,a,b,b-d6)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)